1384P Efficacy of cemiplimab as monotherapy or in combination with chemotherapy in Japanese patients with advanced non-small cell lung cancer (aNSCLC) von Sato, Y., Tani, Y., Ishii, H., Katakura, S., Oki, M., Watanabe, Y., Yokoyama, T., Naoki, K., Pouliot, J-F., Paccaly, A.J., Kim, E., Mani, J., Li, S., Lowy, I., Seebach, F., Mathias, M.D., Ikeda, S.

Volltext

127P Phase I study of fianlimab: A human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced NSCLC von Cho, B.C., Dy, G., Kim, T.M., Sarker, D., Hamid, O., Williamson, S., Sang-We, K., Hatim, H., Chen, S., Mani, J., Jankovic, V., Paccaly, A.J., Masinde, S., Lowy, I., Brennan, L., Gullo, G.

Volltext